Emerald Advisers’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,358,056
| Closed | -$21.5M | – | 280 |
|
|
2018
Q2 | $21.5M | Sell |
1,358,056
-193,817
| -12% | -$3.06M | 0.81% | 50 |
|
|
2018
Q1 | $19.7M | Sell |
1,551,873
-178,155
| -10% | -$2.26M | 0.79% | 47 |
|
|
2017
Q4 | $19.8M | Buy |
1,730,028
+151,551
| +10% | +$1.74M | 0.76% | 50 |
|
|
2017
Q3 | $19.3M | Buy |
1,578,477
+384,805
| +32% | +$4.71M | 0.79% | 49 |
|
|
2017
Q2 | $13.7M | Buy |
1,193,672
+591,840
| +98% | +$6.78M | 0.57% | 73 |
|
|
2017
Q1 | $12.5M | Sell |
601,832
-11,400
| -2% | -$237K | 0.51% | 81 |
|
|
2016
Q4 | $12.8M | Buy |
613,232
+202,817
| +49% | +$4.22M | 0.54% | 76 |
|
|
2016
Q3 | $13.4M | Buy |
410,415
+174,222
| +74% | +$5.71M | 0.6% | 61 |
|
|
2016
Q2 | $5.9M | Buy |
+236,193
| New | +$5.9M | 0.28% | 116 |
|